Nasopharyngeal Carcinoma Clinical Trials in Nanning, Guangxi

16 recruitingNanning, Guangxi, China

Showing 116 of 16 trials

Recruiting
Phase 3

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

ChemotherapyRadiotherapyImmune Checkpoint Inhibitor+1 more
Sun Yat-sen University380 enrolled3 locationsNCT05941741
Recruiting
Phase 3

Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC

Nasopharyngeal Carcinoma (NPC)
First Affiliated Hospital of Guangxi Medical University266 enrolled1 locationNCT07459296
Recruiting
Phase 3

Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response

Nasopharyngeal Carcinoma
Sun Yat-sen University593 enrolled26 locationsNCT06239727
Recruiting
Phase 3

Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy

Nasopharyngeal Carcinoma (NPC)
Ming-Yuan Chen456 enrolled12 locationsNCT07328841
Recruiting
Phase 3

40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
Ming-Yuan Chen346 enrolled15 locationsNCT07328854
Recruiting
Phase 1Phase 2

A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.

Recurrent or Metastatic Nasopharyngeal Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd.202 enrolled20 locationsNCT07258979
Recruiting
Phase 2

A Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal Carcinoma Failed or Intolerance to Second-line Therapy

Nasopharyngeal Carcinoma (NPC)
Shanghai Henlius Biotech70 enrolled15 locationsNCT06839066
Recruiting
Phase 3

Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma

Radiotherapy; ComplicationsNasopharyngeal Carcinoma
Sun Yat-sen University474 enrolled7 locationsNCT05780372
Recruiting
Not Applicable

Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy

Locally Advanced Nasopharyngeal Carcinoma
First Affiliated Hospital of Guangxi Medical University190 enrolled20 locationsNCT05892354
Recruiting
Phase 3

Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
Sun Yat-sen University454 enrolled8 locationsNCT05979961
Recruiting

Diagnostic Accuracy of EBV C Promoter Methylation Kit in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
Sun Yat-sen University908 enrolled5 locationsNCT06445088
Recruiting
Phase 2

Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma

Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University100 enrolled7 locationsNCT05011227
Recruiting

Sintilimab in Combination With Chemoradiotherapy in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma

Nasopharyngeal CarcinomaSintilimab
Cancer Hospital of Guangxi Medical University43 enrolled1 locationNCT05707819
Recruiting
Phase 2

Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC

Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University77 enrolled8 locationsNCT05350891
Recruiting
Phase 3

Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma

Recurrent Nasopharyngeal Carcinoma
Cancer Hospital of Guangxi Medical University204 enrolled1 locationNCT04376866
Recruiting
Not Applicable

Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma Patients

Endoscopic SurgeryNasopharyngeal CarcinomaPrimary Napharyngeal Carcinama+1 more
Sun Yat-sen University228 enrolled5 locationsNCT03353467